2 - 4 April 2020
Verona, Italy

Abstract Submission

Abstracts Submission

Abstract Submission Deadline: 19 January 2020 at 23:59 CET.

Call for Abstracts

The Organising Committee welcomes the submission of abstracts for Oral Presentations, Poster Discussion Presentations and Posters at DHM 2020.

General Abstract Information
Original laboratory research, clinical research and case presentations are equally welcome.

Abstract Regulations
  • Abstracts can only be submitted electronically on the DHM 2020 website.
  • Acknowledgement of receipt of your submission will be sent to your stated email address. If necessary, you may access the abstract and make changes until the submission deadline. If you do not receive the confirmation email within 24 hours, please contact us at: education@eaaci.org.
  • Abstracts must be written in English.
  • Maximum 2,500 characters (approx. 340 words), including spaces but excluding title and contact information of the authors.
  • It is the author's responsibility to submit a fully finalised abstract. Any errors in spelling, grammar or scientific facts will be reproduced as typed by the author.
  • You are allowed to be the presenting author of more than one abstract, three (3) is the maximum number of abstracts that can be presented by the same author.
  • You are allowed to be a co-author of an unlimited number of abstracts.
  • Submission of closely related abstracts from the same group is discouraged.
  • Abstracts will only be considered for presentation if they have not been yet published or submitted for presentation elsewhere.
  • Abstract presenters must be registered for DHM 2020 and pay the registration fee for attendance at the scientific session.

Notification of Acceptance
Accepted abstracts will be considered for oral presentations, poster discussion or poster presentations.
The corresponding author receives all information concerning the abstract and is responsible for informing all other co-authors of the status of the abstract.
All abstract presenters will be asked to reconfirm their attendance after receiving the notification by email. If you do not reconfirm your abstract presentation, register and pay the registration fee before the given deadline, your abstract will be removed from the programme.

Presentation of Abstracts
Accepted abstracts will be presented in Oral Abstract Sessions, Poster Discussion Sessions and Poster Presentation sessions.

Abstract Awards
All accepted abstract presenters will be considered for the DHM 2020 Abstract Awards. Evaluation for these awards will take place during the respective abstract sessions at DHM 2020. Winners will be announced during the closing ceremony. All awardees will be acknowledged on the meeting website.
Abstract Awards will be awarded to the presenting author of the respective abstracts.
For abstract submission support please contact education@eaaci.org.

Abstract Submission Terms and Conditions
1. Authors can modify the author information, category and core data of their abstract directly on the submission system until the deadline given. Please be aware that there will be no extension possible.

2. By submitting this abstract, I understand that my abstract and poster including names, is stored electronically and will be published by the Organising Committee on the EAACI media library. Failure to present your abstract on-site will result in exclusion from online publishing.

3. No trade names of products are allowed in oral or poster presentations. Non-proprietary (generic, chemical) names of drugs should be used. Company names can be used in the authors’ affiliation and as a source to a material mentioned in the body of the abstract, such as “Imiquimod (3M, Milwaukee, USA) was used to stimulate dendritic cells".

4. Abstracts will be reviewed by an expert panel of reviewers. Acceptance of the submitted work is at the discretion of the Scientific Committee.

5. In case the abstract submitter is not the presenting author, the abstract submitter only receives the abstract submission confirmation email. Further communication will be directed to the presenting author only.
The presenting author of an abstract must register for the meeting by the given deadline. If EAACI does not receive your registration and payment by the deadline, your abstract will be removed from the programme.

6. Consent for publication of individual patient data - applies to abstracts with identifiable patient information.
For the publication of an abstract that contains identifiable information about patients it is necessary that patients have given consent for the research to be published. For all abstracts that include identifiable patient details (e.g. gender, age, illness, location) or images, written informed consent for the publication of these must be obtained from the patient (or their parent or legal guardian). By agreeing to these terms, I confirm that:
  • Written informed consent for publication of this clinical details and/or clinical images was obtained from the patient/parent/guardian/relative of the patient. (Please include a respective statement in your abstract text.)
  • The final decision on whether consent to publish is required lies with EAACI.

7. Duplication of publications
EAACI does not accept re-submissions; abstracts must correspond to original, previously unpublished work. By submitting this abstract I confirm that I have not presented/plan to present and publish the abstracts at another meeting, and that I have not submitted/ published the full paper.

8. Declaration of Conflict of Interest
EAACI is committed to ensuring the integrity of its scientific, educational, and research programmes. Abstract submission requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict. The submitter is responsible for obtaining disclosure information from all co-authors, to be entered in the author section of the submission page.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback